Mealey's (October 5, 2020, 1:43 PM EDT) -- WASHINGTON, D.C. — A divided Federal Circuit U.S. Court of Appeals on Oct. 2 found that, contrary to the conclusion reached by a federal judge in Delaware, a jury verdict that Teva Pharmaceuticals USA Inc. induced infringement of a reissue patent is supported by substantial evidence (GlaxoSmithKline LLC, et al. v. Teva Pharmaceuticals USA Inc., No. 18-1976, Fed. Cir.)....